Article Details

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Retrieved on: 2024-12-20 22:47:31

Tags for this article:

Click the tags to see associated articles and topics

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.. View article details on hiswai:

Excerpt

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo